Biogaran sale talks renew fears over foreign control of French pharma

France’s top generic drug maker, Biogaran, could soon be sold to a British investment fund, raising new fears about the country’s control over vital medicines.

Source

(Except for the headline, this story has not been edited by PostX News and is published from a syndicated feed.)